Get the Stockscreener App
7.24
0.84%
0.06
Pre-market:
7.40
0.16
+2.21%
Senseonics Holdings Inc stock is traded at $7.24, with a volume of 452.08K.
It is up +0.84% in the last 24 hours and up +25.48% over the past month.
Senseonics Holdings, Inc., a medical technology company, designs, develops, and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include Eversense and Eversense XL, which are implantable CGM systems that is designed to continually and accurately measure glucose levels in people with diabetes for a period of up to 90 and 180 days. The company has a research and development license agreement with TypeZero Technologies, Inc. and Roche Diabetes Care, Inc. to develop a closed loop diabetes management system that allow users to automatically maintain tight glucose control while avoiding hypoglycemia. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
See More
Previous Close:
$7.18
Open:
$7.3
24h Volume:
452.08K
Relative Volume:
0.65
Market Cap:
$377.95M
Revenue:
$40.71M
Net Income/Loss:
$-87.19M
P/E Ratio:
-3.6178
EPS:
-2.0012
Net Cash Flow:
$-76.28M
1W Performance:
+1.54%
1M Performance:
+25.48%
6M Performance:
+6.63%
1Y Performance:
-27.86%
1-Day Range:
$7.13
$7.43
1-Week Range:
$7.01
$7.6943
52-Week Range:
$4.79
$12.58
Senseonics Holdings Inc Stock (SENS) Company Profile
Name
Senseonics Holdings Inc
Sector
Industry
Phone
301-515-7260
Address
20451 Seneca Meadows Parkway, Germantown, MD
Compare SENS vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SENS
Senseonics Holdings Inc
|
7.24 | 377.95M | 40.71M | -87.19M | -76.28M | -2.0012 |
ABT
Abbott Laboratories
|
88.67 | 154.45B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.94 | 118.05B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
80.38 | 103.20B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
46.76 | 69.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.28 | 49.68B | 6.30B | 1.07B | 1.09B | 1.8406 |
Senseonics Holdings Inc Stock (SENS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-21-25 | Resumed | Stifel | Hold |
| Aug-27-25 | Initiated | Barclays | Overweight |
| Jul-15-25 | Initiated | TD Cowen | Buy |
| Jun-02-25 | Resumed | H.C. Wainwright | Buy |
| Apr-10-25 | Initiated | Mizuho | Outperform |
| Jul-19-23 | Initiated | Jefferies | Underperform |
| Aug-19-21 | Initiated | H.C. Wainwright | Buy |
| Apr-01-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Mar-05-21 | Downgrade | Raymond James | Mkt Perform → Underperform |
| Jan-21-21 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-20-21 | Downgrade | Craig Hallum | Hold → Sell |
| Aug-11-20 | Upgrade | BTIG Research | Neutral → Buy |
| Aug-11-20 | Upgrade | Craig Hallum | Sell → Hold |
| Mar-13-20 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-13-20 | Downgrade | Guggenheim | Buy → Neutral |
| Nov-13-19 | Downgrade | Canaccord Genuity | Buy → Hold |
| Nov-13-19 | Downgrade | Craig Hallum | Buy → Hold |
| Oct-23-19 | Initiated | Stifel | Buy |
| Jul-05-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-29-19 | Initiated | Piper Jaffray | Neutral |
| Aug-24-18 | Initiated | Dougherty & Company | Buy |
View All
Senseonics Holdings Inc Stock (SENS) Latest News
Senseonics Expands Eversense 365 Ecosystem With Welldoc Partnership - Yahoo Finance
Senseonics and Welldoc Partner to Develop Next-Generation App for Eversense® 365 - The Manila Times
SENS Q1 2026 Earnings: Small EPS Miss but Stock Advances on Sustained MomentumNet Profit Margin - newsline.com
Senseonics Holdings (SENS) price target decreased by 11.89% to 17.00 - MSN
Lake Street Maintains Senseonics(SENS.US) With Buy Rating, Maintains Target Price $12 - Moomoo
Senseonics Expands European Eversense CGM Operations via Asset Deals - TipRanks
Eversense 365 Shows Year-Long Accuracy in 12K+ Study - Medical Device and Diagnostic industry
Senseonics completes European asset purchases for Eversense CGM in four countries - TradingView
Senseonics (Nasdaq: SENS) completes Eversense CGM asset buys in key EU markets - Stock Titan
H.C. Wainwright Maintains Senseonics(SENS.US) With Buy Rating, Maintains Target Price $14 - Moomoo
SENS Q1 2026 Earnings: EPS Misses Estimates Amid Continued Operational ChallengesTrough Earnings Signal - newsline.com
Senseonics (SENS) Reveals New Data on Eversense 365 Performance - GuruFocus
Senseonics Reports Strong Performance Metrics for Eversense 365 Continuous Glucose Monitoring System in Real-World Study - Quiver Quantitative
Real-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop Systems - marketscreener.com
SENS: Eversense 365 drives growth as pipeline advances toward fully implantable, invisible CGMs - TradingView
SENS: Eversense 365 drives growth as new implantable CGMs near launch, boosting revenue outlook - TradingView
Implantable Eversense 365 shows 1-year diabetes control in real-world study - Stock Titan
The $5 Signal: Why Senseonics’ Capital Raise Is Dragging SENS Stock Down - Stocktwits
SENS Stock Price, Quote & Chart | SENSEONICS HOLDINGS INC (NASDAQ:SENS) - ChartMill
Senseonics Highlights Analyst Event and Oral Presentation of Eversense 365 Real-World Evidence at ADA 2026 - The Manila Times
One-year implantable glucose monitor gets ADA 2026 oral presentation - Stock Titan
Senseonics Holdings Q1 2026 Earnings: Wider-than-Expected Loss Amid Ongoing Product CommercializationNext Quarter Guidance - newsline.com
Senseonics (SENS) Surges 6.33% as Shares Approach Key Resistance LevelSuperTrend - newsline.com
SENS News | SENSEONICS HOLDINGS INC (NASDAQ:SENS) - ChartMill
SENS Technical Analysis | Trend, Signals & Chart Patterns | SENSEONICS HOLDINGS INC (NASDAQ:SENS) - ChartMill
SENS Q1 2026 Earnings: EPS Misses Estimates Amid Ongoing Operational ChallengesProfit Growth Outlook - newsline.com
Senseonics (SENS) CMO granted 63,177 RSUs and options on 86,935 shares - Stock Titan
[Form 4] Senseonics Holdings, Inc. Insider Trading Activity - Stock Titan
Senseonics (NYSE: SENS) COO awarded new RSUs and stock options - Stock Titan
Senseonics (SENS) director awarded 9,852 RSUs and 13,574 options in equity grants - Stock Titan
Senseonics (SENS) director awarded RSUs and stock options as compensation - Stock Titan
Equity grants to Senseonics (SENS) director add RSUs and options - Stock Titan
Senseonics (SENS) director Sharon Larkin receives RSU and option grants - Stock Titan
Senseonics (SENS) director Douglas Prince receives new equity awards - Stock Titan
Senseonics (SENS) director receives new RSU and stock option grants - Stock Titan
Senseonics (NYSE: SENS) CFO granted RSUs and stock options - Stock Titan
Senseonics (SENS) CCO receives RSU and stock option grants in new Form 4 - Stock Titan
Senseonics (SENS) CEO awarded 553,701 RSUs and 761,923 stock options - Stock Titan
Senseonics Holdings stock (US81725T1007): shareholders approve big share increase after reverse spli - AD HOC NEWS
Senseonics shareholders approve share increase and board elections at annual meeting - Investing.com Canada
Senseonics Shareholders Approve Doubling Authorized Common Stock - TipRanks
Shareholders of Senseonics (NYSE: SENS) back charter change and 2026 equity plan - Stock Titan
Senseonics (SENS) CFO share withholding covers taxes on vested stock units - Stock Titan
Senseonics (SENS) CMO logs Form 4 tax-withholding on 6,058 RSU shares - Stock Titan
Senseonics (NYSE: SENS) COO withholds 13,681 shares to cover tax obligations - Stock Titan
Senseonics (NYSE: SENS) CEO has 28,598 shares withheld for RSU taxes - Stock Titan
Senseonics (SENS) GC uses 7,320 shares to cover RSU tax obligations - Stock Titan
Senseonics Holdings Inc (FRA:6L60) Stock Price, Trades & News - GuruFocus
Senseonics Holdings (SENS) reports Q1 loss, beats revenue estimates - MSN
Q4 2025 Senseonics Holdings Inc Earnings Call Transcript - GuruFocus
Q1 2026 Senseonics Holdings Inc Earnings Call Transcript - GuruFocus
Senseonics Holdings Inc Stock (SENS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.35%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):